Live
Sequence Screening
Multi-approach biosecurity analysis
Multi-layered screening that catches harmful sequences standard BLAST-based analysis misses — combining sequence, structural, and functional signals.
Launch →Prevent biosecurity threats before they emerge.
Build the security infrastructure that scales with biology's potential.
So breakthrough science doesn't become a breakthrough threat.
Scientists self-pause recombinant DNA work to write the first safety norms.
A weaponized pathogen mailed inside the U.S. resets biosecurity policy.
Gain-of-function research forces a global debate on what to publish.
Synthesis providers harmonize on a voluntary screening standard.
A pandemic proves synthetic biology can deploy globally in months.
AI-designed proteins and LLMs raise the ceiling, and the risk surface.
Europe codifies biosecurity expectations across the biotech value chain.
Microsoft shows how AI-paraphrased sequences slip past existing screens.
U.S. Biosecurity Modernization & Innovation Act enters legislative debate.
A complete security layer for biosynthesis, built for what comes next.
Embedded screening, vetting, and modeling tools that sit inside the synthesis workflow.
Multi-layered screening that catches harmful sequences standard BLAST-based analysis misses — combining sequence, structural, and functional signals.
Launch →Compliance checks for biological material orders. Flag high-risk actors before synthesis begins.
High-fidelity in silico environments to model novel pathogen behavior before any wet-lab work begins.
Tools for governments, public-health agencies, and response teams — supporting the wider biosecurity perimeter beyond the synthesis floor.
Full-fidelity outbreak scenario simulations to train teams and stress-test containment protocols.
Live monitoring of pathogen outbreak signals across global health networks, flagging biosecurity-relevant events as they emerge.